Global Non-Alcoholic Steatohepatitis Biomarkers Market Size, Share, Forecast 2034
Non-Alcoholic Steatohepatitis Biomarkers Market By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarke, Others), By End-User (Research Institutes and Academics, Diagnostic Centres, Pharmaceutical Companies and CROs, Hospitals and Clinics, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 267 Report Code: ZMR-6113
Published Date: May-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.51 Billion | USD 13.18 Billion | 24.16% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market, (2022 - 2028) (USD Million)
- 2.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market : snapshot
- Chapter 3. Global Non-Alcoholic Steatohepatitis Biomarkers Market - Industry Analysis
- 3.1 Non-Alcoholic Steatohepatitis Biomarkers Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in NAFLD and NASH prevalence is predicted to drive global market
- 3.3 Market Restraints
- 3.3.1. Lack of professionals and high infrastructure requirements is restraining the market growth
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Biomarker Type
- 3.7.2 Market attractiveness analysis By End-User
- Chapter 4. Global Non-Alcoholic Steatohepatitis Biomarkers Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Non-Alcoholic Steatohepatitis Biomarkers Market - Biomarker Type Analysis
- 5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By Biomarker Type
- 5.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market share, By Biomarker Type, 2021 and 2028
- 5.2 Serum Biomarkers
- 5.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Serum Biomarkers, 2022 - 2028 (USD Million)
- 5.3 Biomarker Panels
- 5.3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Biomarker Panels, 2022 - 2028 (USD Million)
- 5.4 Fibrosis Biomarkers
- 5.4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Fibrosis Biomarkers, 2022 - 2028 (USD Million)
- 5.5 Imaging Biomarkers
- 5.5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Imaging Biomarkers, 2022 - 2028 (USD Million)
- 5.6 Others
- 5.6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
- 5.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By Biomarker Type
- Chapter 6. Global Non-Alcoholic Steatohepatitis Biomarkers Market - End-User Analysis
- 6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By End-User
- 6.1.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market share, By End-User, 2021 and 2028
- 6.2 Hospitals
- 6.2.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Hospitals, 2022 - 2028 (USD Million)
- 6.3 Diagnostic Centers
- 6.3.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Diagnostic Centers, 2022 - 2028 (USD Million)
- 6.4 Others
- 6.4.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
- 6.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market overview: By End-User
- Chapter 7. Non-Alcoholic Steatohepatitis Biomarkers Market - Regional Analysis
- 7.1 Global Non-Alcoholic Steatohepatitis Biomarkers Market Regional Overview
- 7.2 Global Non-Alcoholic Steatohepatitis Biomarkers Market Share, by Region, 2021 & 2028 (USD Million)
- 7.3. North America
- 7.3.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.3.1.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
- 7.3.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
- 7.4.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
- 7.5 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
- 7.5.1 North America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
- 7.4. Europe
- 7.4.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4.2.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
- 7.4.2 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
- 7.4.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
- 7.5 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
- 7.5.1 Europe Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.5.3.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
- 7.5.3 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
- 7.4.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
- 7.5 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
- 7.5.1 Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
- 7.6. Latin America
- 7.6.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.6.4.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
- 7.6.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
- 7.4.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
- 7.5 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
- 7.5.1 Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.7.5.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Country, 2022 - 2028 (USD Million)
- 7.7.5 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 7.4 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028
- 7.4.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by Biomarker Type, 2022 - 2028 (USD Million)
- 7.5 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028
- 7.5.1 The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, by End-User, 2022 - 2028 (USD Million)
- Chapter 8. Company Profiles
- 8.1 Biopredictive
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Quest Diagnostics
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Exalenz Bioscience Ltd
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 GENFIT
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Siemens Healthineers
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 ONE WAY LIVER
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 S.L
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Prometheus Laboratories Inc
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Gilead Sciences Ltd.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.1 Biopredictive
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Non-Alcoholic Steatohepatitis Biomarkers Market attractiveness, By Biomarker Type
- 6. Global Non-Alcoholic Steatohepatitis Biomarkers Market attractiveness, By End-User
- 7. Global Non-Alcoholic Steatohepatitis Biomarkers Market share by Biomarker Type, 2022 and 2028 (USD Million)
- 8. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Serum Biomarkers, 2022 - 2028 (USD Million)
- 9. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Biomarker Panels, 2022 - 2028 (USD Million)
- 10. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Fibrosis Biomarkers, 2022 - 2028 (USD Million)
- 11. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Imaging Biomarkers, 2022 - 2028 (USD Million)
- 12. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
- 13. Global Non-Alcoholic Steatohepatitis Biomarkers Market share by End-User, 2022 and 2028 (USD Million)
- 14. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Hospitals, 2022 - 2028 (USD Million)
- 15. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Diagnostic Centers, 2022 - 2028 (USD Million)
- 16. Global Non-Alcoholic Steatohepatitis Biomarkers Market by Others, 2022 - 2028 (USD Million)
- 17. Global Non-Alcoholic Steatohepatitis Biomarkers Market share, by Region, 2022 and 2028
- 18. North America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 19. Europe Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 20. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 21. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
- 22. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market, 2022 - 2028 (USD Million)
Table Of Tables
- 1. Global Non-Alcoholic Steatohepatitis Biomarkers Market: Snapshot
- 2. Drivers of the Non-Alcoholic Steatohepatitis Biomarkers Market: impact analysis
- 3. North America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 4. North America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 5. U.S. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 6. U.S. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 7. Canada Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 8. Canada Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 9. Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 10. Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 11. Germany Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 12. Germany Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 13. France Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 14. France Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 15. U.K. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 16. U.K. Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 17. Italy Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 18. Italy Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 19. Spain Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 20. Spain Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 21. Rest of Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 22. Rest of Europe Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 23. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 24. Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 25. China Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 26. China Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 27. Japan Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 28. Japan Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 29. India Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 30. India Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 31. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 32. South Korea Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 33. South-East Asia Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 34. South-East Asia Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 35. Rest of Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 36. Rest of Asia Pacific Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 37. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 38. Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 39. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 40. Brazil Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 41. Mexico Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 42. Mexico Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 43. Rest of Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 44. Rest of Latin America Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 45. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 46. The Middle-East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 47. GCC Countries Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 48. GCC Countries Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 49. South Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 50. South Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
- 51. Rest of Middle-East Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By Biomarker Type, 2022 - 2028 (USD Million)
- 52. Rest of Middle-East Africa Non-Alcoholic Steatohepatitis Biomarkers Market revenue, By End-User, 2022 - 2028 (USD Million)
Methodology
FrequentlyAsked Questions
Non-alcoholic fatty liver disease (NAFLD), which develops when an excessive amount of fat builds up in the liver and causes inflammation & damage that results in liver scarring, progresses to non-alcoholic steatohepatitis (NASH).
The global non-alcoholic steatohepatitis biomarkers market is expected to grow due to rising prevalence of NASH due to increasing obesity and diabetes rates, demand for non-invasive diagnostic tools, and advancements in biomarker research and technologies.
According to a study, the global non-alcoholic steatohepatitis biomarkers market size was worth around USD 1.51 Billion in 2024 and is expected to reach USD 13.18 Billion by 2034.
The global non-alcoholic steatohepatitis biomarkers market is expected to grow at a CAGR of 24.16% during the forecast period.
North America is expected to dominate the non-alcoholic steatohepatitis biomarkers market over the forecast period.
Leading players in the global non-alcoholic steatohepatitis biomarkers market include Perspectum Diagnostics Ltd., Shenzhen New Industries Biomedical Engineering Co Ltd, One Way Liver SL, BioPredictive, Cisbio, Celerion, Enterome, Echosens, GENFIT, NGM Biopharmaceuticals, Laboratory Corporation of America Holdings, Pacific Biomarkers, Quest Diagnostics Ltd, Prometheus Laboratories Inc, Regulus Therapeutics Inc., Xeptagen SpA, Boehringer Ingelheim GmbH Inc., Bristol-Myers Squibb, AstraZeneca and Pfizer Inc Source: https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984, among others.
The report explores crucial aspects of the non-alcoholic steatohepatitis biomarkers market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
